99 results on '"Kishida D"'
Search Results
2. AB0162 RELATIONSHIPS BETWEEN THE SIGNALING PATHWAY OF BAFF/APRIL AND CIRCULATING B CELLS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
- Author
-
Shimojima, Y., primary, Kishida, D., additional, Ichikawa, T., additional, Takamatsu, R., additional, Nomura, S., additional, and Sekijima, Y., additional
- Published
- 2023
- Full Text
- View/download PDF
3. OP0278-HPR THE RELATIONSHIP BETWEEN HEALTH LITERACY AND TREATMENT STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ACHIEVED LUPUS LOW DISEASE ACTIVITY STATE: THE TRUMP2-SLE PROJECT
- Author
-
Sada, K. E., primary, Miyawaki, Y., additional, Shidahara, K., additional, Nawachi, S., additional, Katayama, Y., additional, Asano, Y., additional, Hayashi, K., additional, Katsuyama, E., additional, Katsuyama, T., additional, Narazaki, M., additional, Matsumoto, Y., additional, Oguro, N., additional, Ishikawa, Y., additional, Sakurai, N., additional, Hidekawa, C., additional, Yoshimi, R., additional, Kishida, D., additional, Ichikawa, T., additional, Shimojima, Y., additional, Kurita, N., additional, Yajima, N., additional, and Fukuhara, Shunichi, additional
- Published
- 2023
- Full Text
- View/download PDF
4. POS1404 SHARED DECISION MAKING AND INTERNET USE FOR GATHERING HEALTH INFORMATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER CROSS-SECTIONAL STUDY
- Author
-
Ichikawa, T., primary, Shimojima, Y., additional, Kishida, D., additional, Yajima, N., additional, Yoshimi, R., additional, Sada, K. E., additional, Miyawaki, Y., additional, Oguro, N., additional, Sakurai, N., additional, Hidekawa, C., additional, Hayashi, K., additional, Shidahara, K., additional, Ishikawa, Y., additional, Sekijima, Y., additional, and Kurita, N., additional
- Published
- 2022
- Full Text
- View/download PDF
5. POS0728 ASSOCIATION BETWEEN TREATMENT GOAL ACHIEVEMENT AND GRIT PERSONALITY CHARACTERISTICS OF ATTENDING PHYSICIAN IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER CROSS-SECTIONAL STUDY
- Author
-
Sada, K. E., primary, Miyawaki, Y., additional, Shidahara, K., additional, Nawachi, S., additional, Katayama, Y., additional, Asano, Y., additional, Hayashi, K., additional, Ohashi, K., additional, Katsuyama, E., additional, Katsuyama, T., additional, Narazaki, M., additional, Matsumoto, Y., additional, Oguro, N., additional, Ishikawa, Y., additional, Sakurai, N., additional, Hidekawa, C., additional, Yoshimi, R., additional, Ichikawa, T., additional, Kishida, D., additional, Shimojima, Y., additional, Kurita, N., additional, and Yajima, N., additional
- Published
- 2022
- Full Text
- View/download PDF
6. POS0822 HYPERTROPHIC PACHYMENINGITIS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: A MULTICENTER SURVEY IN JAPAN
- Author
-
Shimojima, Y., primary, Kishida, D., additional, Ichikawa, T., additional, Kida, T., additional, Yajima, N., additional, Omura, S., additional, Nakagomi, D., additional, Abe, Y., additional, Masatoshi, K., additional, Takizawa, N., additional, Nomura, A., additional, Kukida, Y., additional, Kondo, N., additional, Yasuhiko, Y., additional, Yanagida, T., additional, Endo, K., additional, Hirata, S., additional, Kawahata, K., additional, Matsui, K., additional, Takeuchi, T., additional, Ichinose, K., additional, Kato, M., additional, Yanai, R., additional, Matsuo, Y., additional, Yamasaki, A., additional, Nishioka, R., additional, Takata, T., additional, Moriyama, M., additional, Takatani, A., additional, Ito, T., additional, Miyawaki, Y., additional, Ito-Ihara, T., additional, Kawaguchi, T., additional, Kawahito, Y., additional, and Sekijima, Y., additional
- Published
- 2022
- Full Text
- View/download PDF
7. AB0474 IMPACT OF HEALTH LITERACY ON TRUST IN PHYSICIANS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE TRUMP2-SLE PROJECT
- Author
-
Oguro, N., primary, Yajima, N., additional, Miyawaki, Y., additional, Yoshimi, R., additional, Shimojima, Y., additional, Sada, K. E., additional, Hayashi, K., additional, Shidahara, K., additional, Sakurai, N., additional, Hidekawa, C., additional, Kishida, D., additional, Ichikawa, T., additional, Ishikawa, Y., additional, and Kurita, N., additional
- Published
- 2022
- Full Text
- View/download PDF
8. THU0052 RELATIONSHIP BETWEEN INTERFERON-Γ-PRODUCING IMMUNOCOMPETENT CELLS AND DISEASE ACTIVITY IN ADULT-ONSET STILL’S DISEASE
- Author
-
Shimojima, Y., primary, Kishida, D., additional, Ichikawa, T., additional, and Sekijima, Y., additional
- Published
- 2020
- Full Text
- View/download PDF
9. Mediterranean fever gene mutations in patients with central nervous inflammation diagnosed with possible neuro-sweet disease
- Author
-
Ishikawa, H., primary, Shindo, A., additional, Ii, Y., additional, Niwa, A., additional, Matsuura, K., additional, Kishida, D., additional, and Hidekazu, T., additional
- Published
- 2017
- Full Text
- View/download PDF
10. Clinical features and treatment outcome of four patients with anti-signal recognition particle antibody positive necrotizing myopathy
- Author
-
Nomura, S., primary, Ueno, A., additional, Miyazaki, D., additional, Kishida, D., additional, Hineno, A., additional, Shimojima, Y., additional, and Sekijima, Y., additional
- Published
- 2017
- Full Text
- View/download PDF
11. RELATIONSHIPS BETWEEN THE SIGNALING PATHWAY OF BAFF/APRIL AND CIRCULATING B CELLS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS.
- Author
-
Shimojima, Y., Kishida, D., Ichikawa, T., Takamatsu, R., Nomura, S., and Sekijima, Y.
- Published
- 2023
- Full Text
- View/download PDF
12. THE RELATIONSHIP BETWEEN HEALTH LITERACY AND TREATMENT STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ACHIEVED LUPUS LOW DISEASE ACTIVITY STATE: THE TRUMP2-SLE PROJECT.
- Author
-
Sada, K. E., Miyawaki, Y., Shidahara, K., Nawachi, S., Katayama, Y., Asano, Y., Hayashi, K., Katsuyama, E., Katsuyama, T., Narazaki, M., Matsumoto, Y., Oguro, N., Ishikawa, Y., Sakurai, N., Hidekawa, C., Yoshimi, R., Kishida, D., Ichikawa, T., Shimojima, Y., and Kurita, N.
- Published
- 2023
- Full Text
- View/download PDF
13. Transient pulmonary edema following Adrenal Infarction in a patient with primary Anti-phospholipid syndrome
- Author
-
Ozawa, K., primary, Tazawa, K., additional, Kishida, D., additional, Fukushima, K., additional, Matsuda, M., additional, and Ikeda, S., additional
- Published
- 2012
- Full Text
- View/download PDF
14. Low serum complements in idiopathic inflammatory myositis: clinical features and impact on the prognosis.
- Author
-
Nomura S, Shimojima Y, Kishida D, Ichikawa T, Matsushima A, and Sekijima Y
- Subjects
- Humans, Female, Middle Aged, Prognosis, Male, Aged, Complement C3 analysis, Adult, Biomarkers blood, Complement System Proteins analysis, Myositis blood, Myositis mortality, Lung Diseases, Interstitial etiology, Lung Diseases, Interstitial blood, Lung Diseases, Interstitial mortality
- Abstract
This study investigated the clinical features and prognostic relevance of decreased serum complement levels in patients with idiopathic inflammatory myositis (IIM). The clinical information of IIM patients with less than normal serum complement levels (L-Com) and that of those with normal serum complement levels (N-Com) was compared. In patients with interstitial lung disease (ILD), regression analyses were used to investigate the implication of L-Com in their PaO
2 /FiO2 (P/F) ratio. Prognostic outcomes of ILD were evaluated using the log-rank test. Of 94 IIM patients, 26 with L-Com (median age, 56.0 years) and 68 with N-Com (56.5 years) were included. The prevalence of women was significantly higher in patients with L-Com (92.3%) than in those with N-Com (67.6%). ILD was observed in 17 (65.4%) patients with L-Com and in 46 (67.6%) with N-Com. Among patients with ILD, the P/F ratio was significantly lower in those with L-Com than in those with N-Com. Serum C3 levels were correlated with decreased P/F ratio. Inferior prognosis of ILD was significantly demonstrated in patients with L-Com, especially in those positive for anti-melanoma differentiation-associated protein 5 antibody. L-Com may be implicated in reduced arterial oxygen levels and a poorer prognosis in patients with IIM-related ILD.- Published
- 2024
- Full Text
- View/download PDF
15. A patient with P369S/R408Q variants in the MEFV gene presented with clinical features of Kikuchi disease and Mollaret meningitis, successfully treated with colchicine.
- Author
-
Handa H, Sugiyama A, Kubosawa H, Nakagawa Y, Kishida D, Uzawa A, Aotsuka A, and Kuwabara S
- Subjects
- Humans, Female, Adult, Cytoskeletal Proteins genetics, Pyrin genetics, Colchicine therapeutic use, Histiocytic Necrotizing Lymphadenitis drug therapy, Histiocytic Necrotizing Lymphadenitis genetics, Histiocytic Necrotizing Lymphadenitis diagnosis
- Abstract
Background: This case report presents the case of a patient with P369S and R408Q variants in the MEFV gene who exhibited clinical features of Kikuchi disease and Mollaret meningitis. Furthermore, it discusses colchicine as a new potential treatment option for Kikuchi disease-associated meningitis., Case Presentation: A 41-year-old Japanese woman presented with fever and headache. She had nuchal rigidity and bilateral cervical lymphadenopathies. Her past medical history included multiple episodes of aseptic meningitis and cervical lymphadenopathy for more than twenty years. Lumbar puncture showed increased lymphocytes and IL-6 level and pathognomonic Mollaret cells. Excisional lymph node biopsy revealed histiocytic necrotizing lymphadenitis, confirming the diagnosis of Kikuchi disease. Subsequently, her recurrent Kikuchi disease and meningitis were successfully treated with colchicine. Furthermore, genetic analysis of the MEFV gene revealed heterozygous P369S/R408Q variants in exon 3., Conclusion: Mollaret meningitis can be associated with Kikuchi disease, and recurrence of both conditions may be suppressed by colchicine when these two coexist., Competing Interests: Declarations Ethics approval and consent to participate Not applicable. Consent for publication Written informed consent for publication of the clinical details was obtained from the patient. Competing interests The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
16. Association between discontinuity of care and patient trust in the usual rheumatologist among patients with systemic lupus erythematosus: a cross-sectional study.
- Author
-
Katayama Y, Miyawaki Y, Shidahara K, Nawachi S, Asano Y, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Oguro N, Yajima N, Ishikawa Y, Sakurai N, Hidekawa C, Yoshimi R, Ohno S, Ichikawa T, Kishida D, Shimojima Y, Sada KE, Wada J, Thom DH, and Kurita N
- Subjects
- Humans, Female, Cross-Sectional Studies, Male, Adult, Middle Aged, Rheumatology methods, Continuity of Patient Care, Lupus Erythematosus, Systemic psychology, Lupus Erythematosus, Systemic therapy, Trust, Physician-Patient Relations, Rheumatologists psychology
- Abstract
Background: Patient trust plays a central role in the patient-physician relationship. This study aimed to determine whether the number of outpatient visits with a covering rheumatologist is associated with patient trust in their usual rheumatologist., Methods: Japanese adults with systemic lupus erythematosus (SLE) who met the 1997 revised classification criteria of the American College of Rheumatology and had outpatient visits with a covering rheumatologist in the past year were included. We used the 11-item Japanese version of the modified Trust in Physician Scale (range 0-100) to assess patient trust. A general linear model with cluster-robust variance estimation was used to evaluate the association between the number of outpatient visits with covering rheumatologists and the patient's trust in their usual rheumatologist., Results: Of the 515 enrolled participants, 421 patients with SLE were included in our analyses. Patients were divided into groups according to the number of outpatient visits with a covering rheumatologist in the past year as follows: no visits (59.9%; reference group), one to three visits (24.2%; low-frequency group), and four or more visits (15.9%; high-frequency group). The median Trust in Physician Scale score was 81.8 (interquartile range: 72.7-93.2). Both the low-frequency group (mean difference: -3.03; 95% confidence interval [CI] -5.93 to -0.80) and high-frequency group (mean difference: -4.17; 95% CI -7.77 to -0.58) exhibited lower trust in their usual rheumatologist., Conclusion: This study revealed that the number of outpatient visits with a covering rheumatologist was associated with lower trust in a patient's usual rheumatologist., Competing Interests: Declarations Ethics approval and consent to participate This study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the Graduate School of Medical and Dental Sciences of Okayama University and the Okayama University Hospital Ethics Committee (approval number: 2204–020). Consent for publication All patients provided informed consent before enrolment. Competing interests Dr. Kurita reported receiving grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payments for speaking at and participating in educational events from Chugai Pharmaceutical Co., Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. Dr. Sada reported receiving a research grant from Pfizer, Inc. and a payment for speaking at and participating in educational events from GlaxoSmithKline K.K. Dr. Wada reported receiving speaker honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Kyowa Kirin, Novo Nordisk, and Mitsubishi Tanabe, and received grant support from Bayer, Chugai, Kyowa Kirin, Otsuka, Shionogi, Sumitomo, and Mitsubishi Tanabe. Dr. Matsumoto reported receiving grants from Asahi Kasei Pharma, Taisho, and AbbVie; received speaker honoraria from Astra Zeneca, Asahi Kasei Pharma, GlaxoSmithKline, and Pfizer, Inc.; and received a payment for participating in educational events from GlaxoSmithKline., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
17. HLA-E-expressing macrophage polarization and increased NKG2A/CD94 expression in adult-onset Still's disease.
- Author
-
Shimojima Y, Ichikawa T, Kishida D, Takamatsu R, and Sekijima Y
- Subjects
- Humans, Male, Adult, Female, Middle Aged, Cells, Cultured, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes metabolism, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes metabolism, Cell Differentiation immunology, NK Cell Lectin-Like Receptor Subfamily C metabolism, NK Cell Lectin-Like Receptor Subfamily C immunology, HLA-E Antigens, Macrophages immunology, Macrophages metabolism, Still's Disease, Adult-Onset immunology, Still's Disease, Adult-Onset diagnosis, Still's Disease, Adult-Onset blood, NK Cell Lectin-Like Receptor Subfamily D metabolism, NK Cell Lectin-Like Receptor Subfamily D immunology, Killer Cells, Natural immunology, Killer Cells, Natural metabolism, Histocompatibility Antigens Class I metabolism, Histocompatibility Antigens Class I immunology
- Abstract
We investigated the phenotypic characteristics of human leukocyte antigen (HLA)-E-expressing macrophages, NKG2A/CD94 expression in T and natural killer (NK) cells, and their interactions in patients with adult-onset Still's disease (AOSD). Peripheral blood mononuclear cells from 22 patients with AOSD and 22 healthy controls (HC) were used. Isolated monocytes were cultured first with macrophage colony-stimulating factor to differentiate into M0 macrophages and subsequently with lipopolysaccharide/interferon-γ or interleukin-4 to differentiate into M1 or M2 macrophages, respectively. HLA-E and NKG2A/CD94 expression levels were evaluated using quantitative RT-PCR and flow cytometry. HLA-E expression in M0 and M2 macrophages was significantly higher in patients with AOSD than in HC, and was positively correlated with serum C-reactive protein levels and erythrocyte sedimentation rate. NKG2A/CD94 expression in CD4 + and CD8 + T cells was significantly higher in patients with AOSD than in HC, but that in NK cells was not significantly different. In patients with AOSD, NKG2A expression in CD4 + T cells positively correlated with HLA-E expression in M0, M1, and M2 macrophages. CD94 expression in CD8 + T cells inversely correlated with HLA-E expression in M1 and M2 macrophages. NKG2A and CD94 expression in NK cells inversely correlated with HLA-E expression in M0, M1, and M2 macrophages. No significant correlation was observed between HLA-E and NKG2A/CD94 expression in HC. Increased expression of HLA-E in macrophages and NKG2A/CD94 in T cells can be observed in the inflammatory condition of AOSD. HLA-E-expressing macrophages may be associated with NKG2A/CD94 expression in T and NK cells with different correlations., Competing Interests: Declarations Ethics approval This study was approved by the local ethics committee of Shinshu University (approval number: 601/727). Patient consent All participants provided written informed consent. Competing interests The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
18. Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
- Author
-
Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, and Nakajima H
- Abstract
Objective: We aimed to gather real-world clinical evidence of detailed disease activity, treatments, remission rates, and adverse events (AEs) associated with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome in a prospective study., Methods: Patients in Japan suspected of having VEXAS syndrome were enrolled in a registry study. A novel disease activity measure (VEXASCAF) assessing 11 symptoms associated with VEXAS syndrome was evaluated at enrolment and after 3 months. AEs, survival, CRP levels, and treatments were also recorded at enrolment and 3 months after enrolment. All exons of UBA1 were sequenced using a next-generation sequencer to determine the variant allele frequencies of pathogenic variants in the peripheral blood of all patients., Results: Of the 55 registered patients, 30 patients were confirmed to have pathogenic variants of UBA1. All patients were male, with a median age of 73.5 years. VEXASCAF and CRP levels decreased significantly at 3 months post-enrolment, but the oral prednisolone dose did not change. Only two patients achieved complete remission according to FRENVEX at 3 months after enrolment. During the observation period of 6 months, 28 AEs were observed, including 3 deaths, 4 malignancies from two cases, 2 thromboses, and 13 infections (including 4 mycobacterial infections). Inflammation of the lung and cervical region (i.e. parotid and submandibular gland swelling, tonsillitis, cervical swelling, and pain) were the most common AEs., Conclusions: Patients with VEXAS syndrome required high-dose glucocorticoids to achieve remission, and complications-such as malignancy, thrombosis, and infection-occurred frequently within a short observation period., (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
19. Impact of multiple MEFV variants of unknown significance on the diagnosis and clinical presentation of familial Mediterranean fever.
- Author
-
Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Ichikawa T, Shimojima Y, and Sekijima Y
- Subjects
- Humans, Female, Male, Adult, Genetic Testing, Adolescent, Mutation, Genetic Variation, Young Adult, Follow-Up Studies, Middle Aged, Genetic Predisposition to Disease, Child, Familial Mediterranean Fever genetics, Familial Mediterranean Fever diagnosis, Pyrin genetics, Colchicine therapeutic use
- Abstract
The detection of variants of unknown significance (VUS) in familial Mediterranean fever (FMF) is common; however, their diagnostic value remains elusive, and the interpretation of multiple VUS remains difficult. Therefore, we examined FMF diagnosis-associated factors 1-year post-genetic testing in patients with only VUS and assessed the impact of multiple VUS on diagnosis and clinical features. A 1-year follow-up was conducted on patients clinically suspected of having FMF without confirmatory diagnosis owing to the presence of only VUS. Clinical features were compared between patients with a single VUS and those with multiple VUS among patients diagnosed with FMF. Among 261 patients followed up, 202 were diagnosed with FMF based on clinical judgment. No specific clinical symptoms or variant patterns at genetic testing were associated with diagnosis at 1 year. Multiple VUS was significantly and independently associated with a lower response to colchicine than single VUS among patients diagnosed with FMF. However, clinical symptoms showed no correlation with the number of VUS. In conclusion, predicting FMF diagnosis 1-year post-genetic testing in patients with only VUS remains challenging. Moreover, the impact of multiple VUS on FMF may be limited owing to the lack of correlation with clinical features, except colchicine response.
- Published
- 2024
- Full Text
- View/download PDF
20. Effect of Shared Decision-Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study.
- Author
-
Yoshimi R, Yajima N, Hidekawa C, Sakurai N, Oguro N, Shidahara K, Hayashi K, Ichikawa T, Kishida D, Miyawaki Y, Sada KE, Shimojima Y, Ishikawa Y, Yoshioka Y, Kunishita Y, Kishimoto D, Takase-Minegishi K, Kirino Y, Ohno S, Kurita N, and Nakajima H
- Abstract
Objective: Few studies have explored whether the involvement of patients in shared decision-making (SDM) is beneficial to the management of systemic lupus erythematosus (SLE). Therefore, this study investigated the relationship between patient participation in SDM and their trust in physicians using data from the Trust Measurement in Physicians and Patients With SLE (TRUMP2-SLE) study., Methods: Data regarding the nine-item Japanese version of the Shared Decision-Making Questionnaire (SDM-Q-9) scores, Trust in Physician Scale (TIPS) scores, and Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) scores for interpersonal trust in a physician and trust in the medical profession were collected from patients with SLE who visited the outpatient clinics of five facilities in Japan through a self-administered questionnaire. The relationships among these scores were analyzed by general linear models with cluster-robust variance., Results: This study included 433 patients with SLE. The median baseline TIPS and A-WFPTS (attending physician version) scores were 82 (73-93) and 80 (70-95), respectively. A higher baseline SDM-Q-9 score was correlated with an increase in the TIPS score at one year (coefficient per 10-point [pt] increase, 0.94 pts, 95% confidence interval [CI] 0.16-1.72). A higher baseline SDM-Q-9 score was correlated with a higher A-WFPTS score for interpersonal trust (coefficient per 10-pt increase, 2.20 pts, 95% CI 1.44-2.96). The baseline SDM-Q-9 score was also correlated with an increase in the general physician version of the A-WFPTS score at one year (coefficient per 10-pt increase, 1.29 pts, 95% CI 0.41-2.18)., Conclusion: Engagement of patients with SLE in SDM elevates their trust in the attending physicians and health care providers, potentially enhancing doctor-patient relationships and overall health care trust., (© 2024 American College of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
21. Headache in systemic lupus erythematosus: The LUNA registry cross-sectional study.
- Author
-
Takamatsu R, Shimojima Y, Kishida D, Ichikawa T, Ueno KI, Miyawaki Y, Yajima N, Sada KE, Ichinose K, Yoshimi R, Ohno S, Kajiyama H, Fujiwara M, Sato S, Kida T, Matsuo Y, Nishimura K, Toriyama T, and Sekijima Y
- Subjects
- Humans, Female, Cross-Sectional Studies, Middle Aged, Male, Adult, Japan epidemiology, Surveys and Questionnaires, Logistic Models, Disability Evaluation, Severity of Illness Index, Multivariate Analysis, Age Factors, Photosensitivity Disorders epidemiology, Photosensitivity Disorders etiology, Aged, Registries, Lupus Erythematosus, Systemic complications, Headache etiology, Headache epidemiology
- Abstract
Objectives: This study investigated the clinically relevant factors for headaches in patients with systemic lupus erythematosus (SLE) using a registry from a Japanese multicenter cohort., Methods: This cross-sectional study analysed the clinical information of patients with SLE who experienced headache episodes using the Migraine Disability Assessment (MIDAS) questionnaire. Significant findings in the comparisons between patients with headache (HA patients) and those without headache (non-HA patients) and in the comparisons depending on the grades of headache-induced disability in daily life based on the MIDAS scores were evaluated. Multivariate logistic regression analyses were performed to identify the relevant factors for headache., Results: We analyzed 369 patients (median age, 45 years; female, 90.8%), including 113 HA patients who were significantly younger than non-HA patients ( p < .005). HA patients had significantly higher frequencies of photosensitivity, rashes, and mucosal ulcers than non-HA patients ( p < .05). Age and photosensitivity were significantly associated with headache (odds ratio (OR) 0.93, 95% confidence interval (CI) 0.95-0.99; OR 2.11, 95% CI 1.29-3.49, respectively). In the HA patients, hypocomplementemia was significantly associated with a disability of more than mild grade (OR 2.89, 95% CI 1.14-7.74), while rash was significantly observed in those presenting with moderate and severe disability., Conclusion: This study suggests that photosensitivity is a relevant manifestation of headache in patients with SLE. Persistent hypocomplementemia can contribute to headache-induced disability in daily life, whereas a rash may be a dominant manifestation in patients presenting with moderate/severe headache-induced disability., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
22. Multiple lymphadenopathies in eosinophilic granulomatosis with polyangiitis: Differentiating from IgG4-related lymphadenopathy.
- Author
-
Kurashina JI, Shimojima Y, Kishida D, Ichikawa T, Uehara T, and Sekijima Y
- Subjects
- Humans, Male, Aged, Diagnosis, Differential, Lymph Nodes pathology, Immunoglobulin G4-Related Disease diagnosis, Immunoglobulin G4-Related Disease complications, Biopsy, Lymphadenopathy etiology, Lymphadenopathy diagnosis, Immunoglobulin G blood, Granulomatosis with Polyangiitis diagnosis, Granulomatosis with Polyangiitis complications
- Abstract
We report a case of eosinophilic granulomatosis with polyangiitis in a 75-year-old man who developed mononeuritis multiplex and purpura in the lower legs concomitantly presenting with lymphadenopathies. Biopsied lymph node tissue pathologically demonstrated fibrinoid necrotising vasculitis with perivascular eosinophil infiltration, resulting in eosinophilic granulomatosis with polyangiitis diagnosis. Additionally, abundant immunoglobulin (Ig) G4-positive plasma cell infiltration exhibiting >70% IgG4/IgG ratio, without storiform pattern fibrosis and obliterative phlebitis, was observed in the biopsied lymph node. Clinical improvement was observed after corticosteroid therapy. IgG4-related lymphadenopathy has been defined as a distinct clinical category regardless of fulfilling IgG4-related disease classification criteria. However, some autoimmune diseases, including eosinophilic granulomatosis with polyangiitis, can develop lymphadenopathy pathologically similar to IgG4-related lymphadenopathy., (© Japan College of Rheumatology 2024. Published by Oxford University Press.)
- Published
- 2024
- Full Text
- View/download PDF
23. Variables for differential diagnosis of familial Mediterranean fever: Multiple correspondence analysis of a large Japanese cohort.
- Author
-
Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Ichikawa T, Shimojima Y, and Sekijima Y
- Subjects
- Humans, Female, Diagnosis, Differential, Male, Adult, Middle Aged, Japan, Young Adult, Adolescent, Stomatitis, Aphthous diagnosis, Cohort Studies, Myelodysplastic Syndromes diagnosis, Myelodysplastic Syndromes genetics, Aged, Colchicine therapeutic use, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases genetics, East Asian People, Familial Mediterranean Fever diagnosis, Familial Mediterranean Fever genetics, Behcet Syndrome diagnosis, Behcet Syndrome genetics
- Abstract
Objectives: We investigated differential diagnoses that should be noted with familial Mediterranean fever (FMF) and useful variables for differentiation in a large Japanese cohort., Methods: Patients aged ≥13 years who were clinically suspected of having FMF by Livneh criteria were studied 1 year after MEFV genetic testing. Patients ultimately diagnosed with other diseases were studied, and the association among each disease, patient characteristics, and clinical variables were analysed using multiple correspondence analysis., Results: In total, 504 patients were included in this study; 34 (6.7%) were diagnosed with a disease other than FMF. The most common diagnosis was Behçet's disease, followed by periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome, inflammatory bowel disease, myelodysplastic syndromes (MDS), and infectious diseases. Although none of the non-FMF patients had exon 10 variants, some responded to colchicine treatment. Multiple correspondence analysis suggested that atypical symptoms such as stomatitis were associated with Behçet's disease and PFAPA syndrome, whereas characteristic situations such as disease onset ≥40 years were associated with MDS and infectious diseases., Conclusion: Careful follow-ups and reanalysis of the diagnosis should be performed for patients with atypical findings and no exon 10 variants, even if their symptoms meet the clinical criteria for FMF., (© Japan College of Rheumatology 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
24. Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis.
- Author
-
Shimojima Y, Nomura S, Ushiyama S, Ichikawa T, Takamatsu R, Kishida D, and Sekijima Y
- Subjects
- Humans, Polyarteritis Nodosa diagnosis, Polyarteritis Nodosa complications, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis complications, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Muscle, Skeletal pathology
- Abstract
Skeletal muscle involvement is common in patients with small- and medium-sized vasculitis, particularly polyarteritis nodosa (PAN) and antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Despite being not included in the standard classification criteria for PAN and AAV, skeletal muscle involvement is an important clinical indicator, particularly when vasculitic myopathy is the only pathological evidence in the absence of other organ involvement. Herein, we comprehensively reviewed and compared the clinical features of 71 and 135 patients with PAN and AAV, respectively, with skeletal muscle involvement at the time of disease onset. Most patients with PAN and AAV exhibited skeletal muscle involvement, often characterized by myalgia and occasional muscular weakness, predominantly in the lower extremities. Myalgia and weakness were observed more frequently in the distal lower extremities in patients with PAN than in those with AAV. In contrast, skeletal muscle involvement tended to exhibit a more dispersed distribution across all four extremities in those with AAV. Muscle magnetic resonance imaging T2-weighted and short-tau inversion recovery sequences can effectively identify hyperintense areas attributed to hypervascularity of affected muscle tissues and serve as a sensitive and useful modality for visually determining the suitable biopsy site. >90% of patients with PAN and AAV demonstrated perivascular inflammation in their affected muscle tissues, whereas fibrinoid necrosis of the vessel walls was reported in two-thirds of patients. Serum creatine kinase (CK) levels were within the normal range in approximately 80% of patients presenting with skeletal muscle involvement in PAN and AAV. Furthermore, muscle fiber damage was milder in patients with skeletal muscle involvement in PAN and AAV than those with idiopathic inflammatory myositis. Meanwhile, serum CK levels were elevated in 65-85% of patients with PAN and AAV who had myofiber necrosis and degeneration in the affected muscles. Most patients with PAN and AAV showed improvement in skeletal muscle involvement following glucocorticoids (GCs) administration; however, relapse was observed in some patients during the tapering of GCs. In summary, skeletal muscle involvement is a potential indicator for establishing PAN and AAV diagnoses during the early phases of the disease., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
25. Immunopathological features of myopathy associated with small-to-medium-sized vessel vasculitis and differences from autoimmune myositis.
- Author
-
Nomura S, Shimojima Y, Ichikawa T, Miyazaki D, Uruha A, Kishida D, and Sekijima Y
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Aged, Biopsy, Fructose-Bisphosphate Aldolase immunology, Fructose-Bisphosphate Aldolase blood, Biomarkers blood, Polyarteritis Nodosa immunology, Polyarteritis Nodosa pathology, Immunohistochemistry, Neural Cell Adhesion Molecules, Vasculitis immunology, Vasculitis pathology, Myositis immunology, Myositis pathology, Muscle, Skeletal pathology, Muscle, Skeletal immunology, Muscle, Skeletal blood supply, Autoimmune Diseases immunology, Autoimmune Diseases pathology, CD56 Antigen analysis, Complement Membrane Attack Complex immunology, Complement Membrane Attack Complex analysis, Complement Membrane Attack Complex metabolism, Platelet Endothelial Cell Adhesion Molecule-1 analysis
- Abstract
Objectives: Patients with systemic vasculitis may develop myalgia as an initial symptom. However, the immunopathology of vasculitic myopathy remains unclear. We investigated the immunopathological features of skeletal muscle in small-to-medium-sized vessel vasculitis., Methods: We analysed muscle tissue biopsies from 15 patients with vasculitis, including antineutrophil cytoplasmic antibodyassociated vasculitis and polyarteritis nodosa, and 15 patients with autoimmune myositis (AIM), including polymyositis and immune-mediated necrotising myopathy, as comparison disease controls. Immunohistochemical staining for CD56/neural cell adhesion molecule (NCAM), major histocompatibility complex class I, C5b-9/membrane attack complex (MAC), and CD31 was performed. The vascularity score was defined as the total number of CD31-expressing blood vessels. The association between CD56/NCAM-expressing myofibers and clinical findings was evaluated in patients with vasculitis., Results: Patients with vasculitis had a significantly lower frequency of CD56/NCAM-expressing myofibers than those with AIM and a positive correlation between the frequency of CD56/NCAM-expressing myofibers and serum aldolase levels. Patients with vasculitis had significantly fewer major histocompatibility complex class I-expressing myofibers and C5b-9/MAC deposits on the sarcolemma than those with AIM. C5b-9/MAC deposits in blood vessels were observed in >70% of patients with vasculitis. Patients with vasculitis had significantly higher vascularity scores in the endomysium than those with AIM., Conclusions: Patients with vasculitis demonstrated mild myofiber damage based on the lower involvement of CD56/NCAM-expressing myofibers compared to those with AIM. Complement component deposits on the vessel walls and hypervascularity in the endomysium areas may be immunopathological features of vasculitic myopathy.
- Published
- 2024
- Full Text
- View/download PDF
26. Effect of Attending Rheumatologists' Big 5 Personality Traits on Patient Trust in Patients With Systemic Lupus Erythematosus: The TRUMP2-SLE Project.
- Author
-
Oguro N, Yajima N, Ishikawa Y, Sakurai N, Hidekawa C, Ichikawa T, Kishida D, Hayashi K, Shidahara K, Miyawaki Y, Yoshimi R, Sada KE, Shimojima Y, and Kurita N
- Subjects
- Adult, Humans, Female, Middle Aged, Male, Trust, Cross-Sectional Studies, Personality, Rheumatologists, Lupus Erythematosus, Systemic
- Abstract
Objective: Differences in communication styles based on physicians' personality traits have been identified, particularly in primary care, and these physician-related factors can be important in building patient-physician trust. This study examined the effects of rheumatologists' personality traits on patients' trust in their attending rheumatologists., Methods: This cross-sectional study included adult Japanese patients with systemic lupus erythematosus (SLE) at 5 academic medical centers between June 2020 and August 2021. The exposures were the Big 5 personality traits (ie, extraversion, agreeableness, openness, conscientiousness, and emotional stability) of attending rheumatologists using the Japanese version of the 10-Item Personality Inventory scale (1-7 points each). The outcome was the patients' trust in their attending rheumatologist using the Japanese version of the 5-item Wake Forest Physician Trust Scale (0-100 points). A general linear model was fitted., Results: The study included 505 patients with a mean age of 46.8 years; 88.1% were women. Forty-three attending rheumatologists (mean age: 39.6 years; 23.3% female) were identified. After multivariable adjustment, higher extraversion and agreeableness were associated with higher trust (per 1-point increase, 3.76 points [95% CI 1.07-6.45] and 4.49 points [95% CI 1.74-7.24], respectively), and higher conscientiousness was associated with lower trust (per 1-point increase, -2.17 points [95% CI -3.31 to -1.03])., Conclusion: Whereas higher extraversion and agreeableness of attending rheumatologists led to higher patient trust in their rheumatologist, overly high conscientiousness may lead to lower trust resulting from the physicians' demand of responsibility and adherence to instructions from patients with SLE., (Copyright © 2024 by the Journal of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
27. Immune-mediated necrotizing myopathy with concomitant development of Kikuchi-Fujimoto disease.
- Author
-
Ichikawa T, Furukawa R, Shimojima Y, Hoshino Y, Kishida D, and Sekijima Y
- Subjects
- Female, Humans, Adult, Prednisolone therapeutic use, Immunosuppressive Agents therapeutic use, Histiocytic Necrotizing Lymphadenitis complications, Histiocytic Necrotizing Lymphadenitis diagnosis, Histiocytic Necrotizing Lymphadenitis drug therapy, Autoimmune Diseases drug therapy, Myositis complications, Myositis diagnosis, Myositis drug therapy, Arthritis, Rheumatoid drug therapy
- Abstract
Immune-mediated necrotizing myopathy (IMNM) is a distinct type of idiopathic inflammatory myositis, pathologically characterized by myofiber necrosis and degeneration in the absence of lymphocyte infiltration. Herein, we present a case of IMNM with concomitant development of Kikuchi-Fujimoto disease (KFD), characterized by histiocytic necrotizing lymphadenitis, in a 36-year-old woman who had a treatment history for rheumatoid arthritis (RA). Treatment with oral prednisolone and tacrolimus as immunosuppressants resulted in the remission of the skeletomuscular involvement and lymphadenopathy. To the best of our knowledge, this is the first report of IMNM and KFD developing concomitantly during the clinical course of RA., (© 2023 The Authors. International Journal of Rheumatic Diseases published by Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
28. Case report: Successful treatment with canakinumab of a patient with active ileitis associated with familial Mediterranean fever.
- Author
-
Kishida D, Hara R, Ichikawa T, Iwaya M, Shimojima Y, and Sekijima Y
- Subjects
- Humans, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal therapeutic use, Colchicine therapeutic use, Familial Mediterranean Fever complications, Familial Mediterranean Fever diagnosis, Familial Mediterranean Fever drug therapy
- Published
- 2024
- Full Text
- View/download PDF
29. Promoting awareness of terminology related to unmet medical needs in context of rheumatic diseases in Japan: a systematic review for evaluating unmet medical needs.
- Author
-
Yamazaki S, Izawa K, Matsushita M, Moriichi A, Kishida D, Yoshifuji H, Yamaji K, Nishikomori R, Mori M, and Miyamae T
- Subjects
- Adult, Humans, Japan, Cross-Sectional Studies, Quality of Life, Rheumatic Diseases diagnosis, Rheumatic Diseases therapy, Arthritis, Juvenile
- Abstract
To optimize patient prognosis, patient needs, including unmet needs, should be adequately assessed. However, such needs are more challenging to report and, consequently, more likely to go unmet compared with the needs reported by physicians. We aimed to determine the appropriate direction of future research on unmet medical needs in rheumatic diseases in Japan by conducting a literature review. We searched PubMed and Web of Science using 23 terms linked to unmet medical needs for major rheumatic diseases in Japan. Further, we collected articles on health-related quality of life and investigated the scales used for assessment, as well as whether the terms "unmet needs" or "unmet medical needs" were used. We identified 949 papers on 10 diseases, including systemic lupus erythematosus, systemic sclerosis, dermatomyositis, juvenile idiopathic arthritis, adult-onset Still's disease, antiphospholipid syndrome, mixed connective tissue disease, Takayasu arteritis, Sjögren's syndrome, and Behçet's disease; 25 of the 949 papers were selected for full-text review. Fifteen articles on five diseases were related to health-related quality of life. The term "unmet needs" was used in only one article. Six out of 15 studies used the 36-item short form survey, whereas the scales used in other studies differed. The optimal treatment plan determined by a physician may not necessarily align with the best interests of the patient. In clinical research, cross sectional and standardized indicators of health-related quality of life should be employed along with highly discretionary questionnaires to assess and optimize resource allocation in healthcare and simultaneously achieve patient-desired outcomes., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
30. Impact of online health information-seeking behavior on shared decision-making in patients with systemic lupus erythematosus: The TRUMP 2 -SLE project.
- Author
-
Ichikawa T, Kishida D, Shimojima Y, Yajima N, Oguro N, Yoshimi R, Sakurai N, Hidekawa C, Sada KE, Miyawaki Y, Hayashi K, Shidahara K, Ishikawa Y, Sekijima Y, and Kurita N
- Subjects
- Humans, Cross-Sectional Studies, Information Seeking Behavior, Patient Participation, Decision Making, Lupus Erythematosus, Systemic therapy
- Abstract
Objective: Providing appropriate health information to patients with systemic lupus erythematosus (SLE) is advantageous in the treatment decision-making process. We aimed to investigate how online health information-seeking behaviors affect shared decision-making (SDM) in patients with SLE., Methods: This cross-sectional study included 464 patients with SLE from five institutions. The main exposure was time spent on the internet per day, divided into four categories (none, <1 h, 1- < 2 h, ≥2 h). Participants categorized their preferred first source of health information as physicians, the internet, or other media. The outcome was the degree of SDM measured via the 9-item Shared Decision-Making Questionnaire (SDM-Q-9). A general linear model was applied., Results: Compared to no internet use, longer internet use was associated with a higher SDM-Q-9 score: <1 h, 6.9 points (95% confidence interval [CI] 0.32 to 13.6) and ≥2 h, 8.75 points, (95% CI 0.61 to 16.9). The SDM-Q-9 did not differ between the individuals who chose physicians and those who chose the Internet as their preferred first source of health information (-2.1 points, 95% CI -6.7 to 2.6). Individuals who chose other media had significantly lower SDM-Q-9 scores than those who chose physicians (-7.6 points, 95% CI -13.2 to -1.9)., Conclusions: The present study suggests that SDM between physicians and patients is positively associated with online information-seeking behavior, with no negative influence associated with accessing the Internet before clinical consultations. Rheumatologists may need to introduce their patients to websites offering high-quality health information to establish a good physician-patient relationship for SDM., Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payments for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and Japan College of Rheumatology. K. Sada has received a research grant from Pfizer Inc. and payments for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
31. The Association of Grit With Burnout Components (Professional Efficacy, Exhaustion, and Cynicism) Among Academic Rheumatologists: The TRUMP 2 -SLE Study.
- Author
-
Miyawaki Y, Sada KE, Shidahara K, Nawachi S, Asano Y, Katayama Y, Hayashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Oguro N, Yajima N, Ishikawa Y, Sakurai N, Hidekawa C, Yoshimi R, Ichikawa T, Kishida D, Shimojima Y, Wada J, and Kurita N
- Subjects
- Child, Humans, Male, Middle Aged, Female, Rheumatologists, Cross-Sectional Studies, Surveys and Questionnaires, Burnout, Professional epidemiology, Physicians, Lupus Erythematosus, Systemic
- Abstract
Objectives: There is a high prevalence of burnout among rheumatologists. Grit, which is defined as possessing perseverance and a passion to achieve long-term goals, is predictive of success in many professions; however, whether grit is associated with burnout remains unclear, especially among academic rheumatologists, who have multiple simultaneous responsibilities. Thus, the purpose of this study was to examine the associations between grit and self-reported burnout components-professional efficacy, exhaustion, and cynicism-in academic rheumatologists., Methods: This cross-sectional study involved 51 rheumatologists from 5 university hospitals. The exposure was grit, measured using mean scores for the 8-item Short Grit Scale (range, 1-5 [5 = extremely high grit]). The outcome measures were mean scores for 3 burnout domains (exhaustion, professional efficacy, and cynicism; range, 1-6; measured using the 16-item Maslach Burnout Inventory-General Survey). General linear models were fitted with covariates (age, sex, job title [assistant professor or higher vs lower], marital status, and having children)., Results: Overall, 51 physicians (median age, 45 years; interquartile range, 36-57; 76% men) were included. Burnout positivity was found in 68.6% of participants (n = 35/51; 95% confidence interval [CI], 54.1, 80.9). Higher grit was associated with higher professional efficacy (per 1-point increase; 0.51 point; 95% CI, 0.18, 0.84) but not with exhaustion or cynicism. Being male and having children were associated with lower exhaustion (-0.69; 95% CI, -1.28, -0.10; p = 0.02; and -0.85; 95% CI, -1.46, -0.24; p = 0.006). Lower job title (fellow or part-time lecturer) was associated with higher cynicism (0.90; 95% CI, 0.04, 1.75; p = 0.04)., Conclusions: Grit is associated with higher professional efficacy among academic rheumatologists. To prevent burnout among staff, supervisors who manage academic rheumatologists should assess their staff's individual grit., Competing Interests: N.K. is a member of the Committee on Clinical Research, Japan College of Rheumatology, and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payments for speaking at and participating in educational events from Chugai Pharmaceutical Co, Ltd, Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. K.S. received a research grant from Pfizer Inc and a payment for speaking at and participating in educational events from GlaxoSmithKline K.K. The other authors declare that they have no conflicts of interest., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
32. Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation.
- Author
-
Nakamura N, Ishikawa H, Matsuyama H, Shindo A, Kishida D, Maeda M, and Tomimoto H
- Subjects
- Humans, Aquaporin 4, Neuromyelitis Optica genetics, Familial Mediterranean Fever genetics
- Published
- 2023
- Full Text
- View/download PDF
33. Features of BAFF and APRIL receptors on circulating B cells in antineutrophil cytoplasmic antibody-associated vasculitis.
- Author
-
Shimojima Y, Kishida D, Ichikawa T, Takamatsu R, Nomura S, and Sekijima Y
- Subjects
- Humans, Antibodies, Antineutrophil Cytoplasmic, Interleukin-6, Tumor Necrosis Factor Ligand Superfamily Member 13 metabolism, B-Cell Activating Factor, B-Cell Activation Factor Receptor, Interleukin-4, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Abstract
To investigate the features of circulating B cells, their expressing receptors, serum levels of B-cell activation factor of the TNF family (BAFF), and a proliferation-inducing ligand (APRIL) in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Blood samples from 24 patients with active AAV (a-AAV), 13 with inactive AAV (i-AAV), and 19 healthy controls (HC) were included in this study. The proportion of B cells and their expressing BAFF receptor (BAFF-R), transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), and B-cell maturation antigen were analyzed via flow cytometry. Serum levels of BAFF, APRIL, and interleukin (IL)-4, IL-6, IL-10, and IL-13 were also evaluated using an enzyme-linked immunosorbent assay. The proportion of plasmablasts (PB)/plasma cells (PC) and serum levels of BAFF, APRIL, IL-4, and IL-6 were significantly higher in a-AAV than in HC. Higher serum levels of BAFF, APRIL, and IL-4 were observed in i-AAV than in HC. Lower expression of BAFF-R on memory B cells and higher expression of TACI on CD19+ cells, immature B cells, and PB/PC were demonstrated in a-AAV and i-AAV than in HC. The population of memory B cells was positively associated with serum APRIL levels and BAFF-R expression in a-AAV. In conclusion, decreased expression of BAFF-R on memory B cells and increased expression of TACI on CD19+ cells, immature B cells, and PB/PC, as well as increased serum levels of BAFF and APRIL, were sustained even in the remission phase of AAV. Persistent aberrant signaling of BAFF/APRIL may contribute to disease relapse., (© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
34. Trust in the attending rheumatologist, health-related hope and medication adherence among Japanese systemic lupus erythematosus patients.
- Author
-
Kurita N, Oguro N, Miyawaki Y, Hidekawa C, Sakurai N, Ichikawa T, Ishikawa Y, Hayashi K, Shidahara K, Kishida D, Yoshimi R, Sada KE, Shimojima Y, and Yajima N
- Subjects
- Female, Humans, Male, Middle Aged, Cross-Sectional Studies, Trust, Hope, Goals, Thinking, Ambulatory Care Facilities, East Asian People psychology, Lupus Erythematosus, Systemic drug therapy, Lupus Erythematosus, Systemic ethnology, Lupus Erythematosus, Systemic psychology, Medication Adherence ethnology, Medication Adherence psychology, Rheumatologists, Physician-Patient Relations
- Abstract
Objective: Poor medication adherence among patients with SLE is a critical problem associated with adverse outcomes. This study examined the relationship between trust in one's physician and goal-oriented thinking, hope and medication adherence among Japanese patients with SLE who were ethnically matched to their physicians., Methods: This cross-sectional study was conducted in the rheumatology outpatient clinics at five academic centres. Patients with SLE who were prescribed oral medications were included. The main exposures were trust in one's physician measured via the 5-item Japanese version of the Wake Forest Physician Trust Scale and the 18-item Health-related Hope Scale, with each score ranging from 0 to 100 points. Medication adherence was measured using the 12-item Medication Adherence Scale with scores ranging from 5 to 60 points. A general linear model was created after adjusting for demographics, socioeconomic status, disease activity, disease duration, basic health literacy, depression, medication variables, experiencing adverse effects and concerns regarding lupus medications., Results: Altogether, 373 patients with SLE were included. The mean age of the patients was 46.4 years; among them, 329 (88.2%) were women. Both trust in one's physician (per 10-point increase: 0.86, 95% CI 0.49, 1.22) and the Health-related Hope score (per 10-point increase: 0.66, 95% CI 0.35, 0.97) were associated with better medication adherence., Conclusions: This study demonstrated that patients' health-related hope and trust in their rheumatologist were both associated with better medication adherence in SLE., (© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
35. Grit personality of physicians and achievement of treatment goals in patients with system lupus erythematosus.
- Author
-
Sada KE, Miyawaki Y, Shidahara K, Nawachi S, Katayama Y, Asano Y, Hayashi K, Ohashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Oguro N, Ishikawa Y, Sakurai N, Hidekawa C, Yoshimi R, Kishida D, Ichikawa T, Shimojima Y, Kurita N, and Yajima N
- Subjects
- Humans, Goals, Cross-Sectional Studies, Personality, Severity of Illness Index, Lupus Erythematosus, Systemic therapy, Physicians
- Abstract
Objectives: Although personality characteristics of patients with SLE affect their disease activity and damage, it is unclear whether those of attending physicians affect the outcomes of patients with SLE. Grit is a personality trait for achieving long-term goals that may influence the decision-making for continuing treatment plans for patients. We aimed to evaluate the relationship between the grit of attending physicians and achievement of treatment goals in patients with SLE., Methods: This cross-sectional study was conducted at five referral hospitals. The main exposure was 'consistency of interest' and 'perseverance of effort' of the attending physicians, measured by the Short Grit Scale. The primary outcome was achievement of a lupus low disease activity state (LLDAS). The association between physicians' grit score and LLDAS was analysed by generalized estimating equation (GEE) logistic regression with cluster robust variance estimation, with adjustment for confounders., Results: The median (interquartile range) total, consistency and perseverance scores of 37 physicians were 3.1 (2.9-3.6), 3.3 (2.8-3.8) and 3.3 (3.0-3.5), respectively. Among the 386 patients, 154 (40%) had achieved LLDAS. Low consistency score (≤2.75) in physicians was related to LLDAS achievement independently using GEE logistic regression. The score of the question 'I often set a goal but later choose to pursue a different one' was significantly higher in patients achieving LLDAS., Conclusions: Difficulty of attending physicians to change treatment goals might be related to lower LLDAS achievement in patients with SLE., (© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
36. Effect of Communicative and Critical Health Literacy on Trust in Physicians Among Patients With Systemic Lupus Erythematosus (SLE): The TRUMP2-SLE Project.
- Author
-
Oguro N, Yajima N, Miyawaki Y, Yoshimi R, Shimojima Y, Sada KE, Hayashi K, Shidahara K, Sakurai N, Hidekawa C, Kishida D, Ichikawa T, Ishikawa Y, and Kurita N
- Subjects
- Humans, Trust, Cross-Sectional Studies, Cohort Studies, Communication, Health Literacy, Physicians, Lupus Erythematosus, Systemic
- Abstract
Objective: Patients who trust their physicians have been shown to demonstrate good medication adherence, self-management, and favorable disease outcomes. This study examines how trust in physicians is affected by functional health literacy (HL) and by broader concepts of HL, including communicative HL and critical HL, among patients with systemic lupus erythematosus (SLE)., Methods: This was a cross-sectional study using baseline data from the Trust Measurement for Physicians and Patients with SLE (TRUMP2-SLE) study, an ongoing multicenter cohort study conducted at 5 academic centers. The 14-item Functional, Communicative, and Critical Health Literacy Scale assessed the 3 dimensions of HL; each item of the scale was scored on a 4-point Likert scale, ranging from 1 to 4. Outcomes were trust in one's physician and trust in physicians in general using the 5-item Wake Forest Physician Trust Scale, which ranged from 0 to 100 points. General linear models were fit., Results: A total of 362 patients with SLE were included. Trust in one's physician increased with higher functional and communicative HL (per 1-point increase: mean difference 3.39, 95% CI 0.39-6.39, and mean difference 5.88, 95% CI 2.04-9.71, respectively). Trust in physicians in general increased with higher communicative HL and decreased with higher critical HL (per 1-point increase: mean difference 7.09, 95% CI 2.34-11.83, and mean difference -6.88, 95% CI -11.72 to -2.04, respectively). Longer internet use was associated with both higher communicative and critical HL., Conclusion: The findings suggest that rheumatologists need to improve their communication to match each patient's HL, which may foster trust and lead to improved self-management and outcomes in SLE. They also suggest that the formation of the rheumatologist-patient relationship may negate the effect of high critical HL in building trust., (Copyright © 2023 by the Journal of Rheumatology.)
- Published
- 2023
- Full Text
- View/download PDF
37. <Editors' Choice> Myelodysplastic syndrome with trisomy 8 presenting periodic fever and multiple MEFV gene variants outside exon 10: a case report.
- Author
-
Takahashi N, Hanajiri R, Suzuki M, Anan C, Inagaki A, Kishida D, Ozawa S, Kohri S, Kamiya N, Sato M, and Sato J
- Abstract
Myelodysplastic syndrome is associated with the development of autoinflammatory conditions, such as recurrent fever, polymyalgia, arthralgia, and erythema. Trisomy 8 is a common chromosomal abnormality in patients with myelodysplastic syndrome. Myelodysplastic syndrome with trisomy 8 involves autoinflammatory conditions, especially Beh ç et's disease-like symptoms with intestinal mucosal damage. MEFV variants, particularly those in exon 10, are pathogenic in familial Mediterranean fever, the most common autoinflammatory disease, presenting typical symptoms such as periodic fever and pleuritis/pericarditis/peritonitis. MEFV variants outside exon 10 are common in Japanese patients with familial Mediterranean fever and are associated with atypical symptoms, including myalgia and erythema. MEFV variants in myelodysplastic syndrome with trisomy 8 have rarely been investigated, although myelodysplastic syndrome with trisomy 8 might develop autoinflammatory conditions similar to those in familial Mediterranean fever. We encountered a 67-year-old man who had myelodysplastic syndrome with trisomy 8 and multiple MEFV variants outside exon 10. He presented with periodic fever, as well as chest/abdominal pain, myalgia, and erythema, although the symptoms did not fulfill the diagnostic criteria of familial Mediterranean fever. We discussed the possibility that these symptoms are modified by MEFV variants outside exon 10 in myelodysplastic syndrome with trisomy 8., Competing Interests: NT reports that his current affiliated institution was established by donations from Aichi Prefecture and Nagoya City, Japan, and that he has received grants and personal fees from Novartis Pharma KK outside the submitted work.
- Published
- 2023
- Full Text
- View/download PDF
38. Testicular vasculitis in eosinophilic granulomatosis with polyangiitis: a case-based review.
- Author
-
Ichikawa T, Shimojima Y, Nomura S, Kishida D, Shiozaki M, Tanimura J, and Sekijima Y
- Subjects
- Male, Humans, Middle Aged, Testis, Adrenal Cortex Hormones therapeutic use, Pain drug therapy, Granulomatosis with Polyangiitis complications, Granulomatosis with Polyangiitis diagnosis, Granulomatosis with Polyangiitis drug therapy, Churg-Strauss Syndrome complications, Churg-Strauss Syndrome diagnosis, Churg-Strauss Syndrome drug therapy
- Abstract
Testicular vasculitis (TV) develops when an organ is involved in systemic vasculitis. A 47-year-old man with eosinophilic granulomatosis with polyangiitis (EGPA) developed TV as the first clinical episode. The patient had bronchial asthma for 8 years and developed left testicular pain before developing arthralgia, abdominal involvement, and sensory polyneuropathy, which led to the diagnosis of EGPA. The induration of the affected testicle persisted even after initiating immunosuppressive therapy with corticosteroids and cyclophosphamide, raising concern for testicular neoplasm, while testicular pain and other symptoms resolved. The patient underwent inguinal orchiectomy, and a histology examination of the resected testicle revealed fibrinoid necrotizing vasculitis. Only three cases of biopsy-proven TV in patients with EGPA have been reported in our review of published English-language articles. Two of the three patients in the reviewed cases developed TV before being diagnosed with EGPA. Moreover, all patients underwent extirpation of the affected testicle, leading to a pathological diagnosis of TV. This report suggests that TV may develop and be the presenting condition in EGPA, although urogenital involvement is rare., (© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).)
- Published
- 2023
- Full Text
- View/download PDF
39. The impact of normal serum complement levels on the disease classification and clinical characteristics in systemic lupus erythematosus.
- Author
-
Takamatsu R, Shimojima Y, Kishida D, Ichikawa T, and Sekijima Y
- Subjects
- Humans, United States, Kidney, Recurrence, Lupus Erythematosus, Systemic, Rheumatology, Rheumatic Diseases
- Abstract
Background: Some patients have normal levels of complement during the diagnosis of systemic lupus erythematosus (SLE), although decreased serum levels of complement are a hallmark of the active phase of the disease. This study investigated the clinical characteristics, impact on the classification of SLE, and the prognosis of patients with SLE who had normal serum complement levels at initial diagnosis (N-com)., Methods: We evaluated 21 patients with N-com and 96 patients with hypocomplementemia at the initial diagnosis of SLE (H-com). The classification rates among the American College of Rheumatology (ACR) 1997, Systemic Lupus International Collaborating Clinics (SLICC) 2012, European League Against Rheumatism (EULAR)/ACR 2019 criteria, and clinical and immunological involvements were compared between SLE patients with N-com and H-com. Relapse and organ damage based on the SLICC/ACR damage index were also evaluated., Results: The classification rates of SLE were not significantly different in the ACR, SLICC, and EULAR/ACR criteria between the N-com and H-com groups. Patients with N-com had no significant differences in the classification rates among the three criteria, whereas patients with H-com had lower classification rates in the ACR criteria than in the SLICC criteria. A lower incidence of renal manifestation, less positivity for anti-dsDNA antibody, and a higher incidence of fever were observed in patients with N-com than in those with H-com. The occurrence of relapse and organ damage was not significantly different between patients with N-com and H-com., Conclusion: Patients with N-com were less involved in renal manifestation and anti-dsDNA antibody positivity but had a higher incidence of fever than those with H-com, while having no disadvantage in SLE classification processes. Serum complement levels at the initial diagnosis of SLE may not predict prognosis., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
40. A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever.
- Author
-
Koga T, Sato S, Hagimori N, Yamamoto H, Ishimura M, Yasumi T, Kirino Y, Ikeda K, Yachie A, Migita K, Kishida D, Atsumi T, and Kawakami A
- Subjects
- Colchicine adverse effects, Humans, Treatment Outcome, Antibodies, Monoclonal, Humanized adverse effects, Familial Mediterranean Fever diagnosis, Familial Mediterranean Fever drug therapy
- Abstract
Objectives: To evaluate the efficacy and safety of tocilizumab (TCZ), an interleukin 6 receptor monoclonal antibody, in a subset of Japanese patients with familial Mediterranean fever (FMF)., Methods: We performed a double-blind, randomised, parallel-group trial, followed by an open-label extension trial, in patients with colchicine-resistant or -intolerant FMF (crFMF) (UMIN000028010). Patients were randomly assigned (1:1) to receive TCZ (162 mg every week) or placebo, administered subcutaneously, for 24 weeks. Rescue treatment was allowed if the rescue criteria were met. The primary endpoint was the number of fever attacks over the 24 weeks of treatment. Secondary endpoints included the frequency of accompanying symptoms during attacks, serum CRP and SAA values, and adverse events (AEs). The open-label extension study evaluated the long-term safety and efficacy of TCZ in patients who had completed the preceding study (UMIN000032557)., Results: We randomly assigned 23 patients to either TCZ (n=1) or placebo (n=12). The TCZ-placebo rate ratios were 0.691 (95% confidence intervals (CI), 0.189-2.531; p=0.577) for the fever attacks, based on the group rates per week. The recurrence of attacks was significantly lower in the TCZ group (hazard ratio = 0.457; 95% CI, 0.240-0.869). Fever attacks, accompanying symptoms, serum CRP and SAA values were controlled in most of the patients who received long-term TCZ. In these trials, the numbers and severity of AEs did not differ between groups., Conclusions: Although a primary endpoint was not met in the preceding trial, long-term administration of TCZ showed stable efficacy and safety for patients with crFMF.
- Published
- 2022
- Full Text
- View/download PDF
41. Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).
- Author
-
Shimojima Y, Kishida D, Ichikawa T, Kida T, Yajima N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Kawaguchi T, Kawahito Y, and Sekijima Y
- Subjects
- Aged, Aged, 80 and over, Antibodies, Antineutrophil Cytoplasmic, Cross-Sectional Studies, Humans, Hypertrophy, Japan epidemiology, Middle Aged, Myeloblastin, Peroxidase, Retrospective Studies, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis complications, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis epidemiology, Granulomatosis with Polyangiitis complications, Granulomatosis with Polyangiitis epidemiology, Meningitis epidemiology
- Abstract
Background: This study investigated the characteristics of hypertrophic pachymeningitis (HP) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), using information from a multicenter study in Japan., Methods: We analyzed the clinical information of 663 Asian patients with AAV (total AAV), including 558 patients with newly diagnosed AAV and 105 with relapsed AAV. Clinical findings were compared between patients with and without HP. To elucidate the relevant manifestations for HP development, multivariable logistic regression analyses were additionally performed., Results: Of the patients with AAV (mean age, 70.2 ± 13.5 years), HP was noted in 30 (4.52%), including 20 (3.58%) with newly diagnosed AAV and 10 (9.52%) with relapsed AAV. Granulomatosis with polyangiitis (GPA) was classified in 50% of patients with HP. A higher prevalence of GPA was significantly observed in patients with HP than in those without HP in total AAV and newly diagnosed AAV (p < 0.001). In newly diagnosed AAV, serum proteinase 3 (PR3)-ANCA positivity was significantly higher in patients with HP than in those without HP (p = 0.030). Patients with HP significantly had ear, nose, and throat (ENT) (odds ratio [OR] 1.48, 95% confidence interval [CI] 1.03-2.14, p = 0.033) and mucous membrane/eye manifestations (OR 5.99, 95% CI 2.59-13.86, p < 0.0001) in total AAV. Moreover, they significantly had conductive hearing loss (OR 11.6, 95% CI 4.51-29.57, p < 0.0001) and sudden visual loss (OR 20.9, 95% CI 5.24-85.03, p < 0.0001)., Conclusion: GPA was predominantly observed in patients with HP. Furthermore, in newly diagnosed AAV, patients with HP showed significantly higher PR3-ANCA positivity than those without HP. The ear and eye manifestations may be implicated in HP development., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
42. Clinical characteristics and treatment of elderly onset adult-onset Still's disease.
- Author
-
Kishida D, Ichikawa T, Takamatsu R, Nomura S, Matsuda M, Ishii W, Nagai T, Suzuki S, Ueno KI, Tachibana N, Shimojima Y, and Sekijima Y
- Subjects
- Adult, Aged, Humans, Immunosuppressive Agents therapeutic use, Retrospective Studies, Cytomegalovirus Infections complications, Macrophage Activation Syndrome complications, Macrophage Activation Syndrome drug therapy, Still's Disease, Adult-Onset complications, Still's Disease, Adult-Onset drug therapy, Still's Disease, Adult-Onset epidemiology
- Abstract
Adult-onset Still's disease (AOSD)-a systemic inflammatory disease-often occurs at a young age. Recently, elderly onset patient proportion has been increasing; however, data are limited. To evaluate the characteristics of elderly patients with AOSD in a multicenter cohort, we retrospectively analyzed 62 patients with AOSD at five hospitals during April 2008-December 2020. Patients were divided into two groups according to age at disease onset: younger-onset (≤ 64 years) and elderly onset (≥ 65 years). Clinical symptoms, complications, laboratory findings, treatment, and outcomes were compared. Twenty-six (41.9%) patients developed AOSD at age ≥ 65 years. The elderly onset group had a lower frequency of sore throat (53.8% vs. 86.1%), higher frequency of pleuritis (46.2% vs. 16.7%), and higher complication rates of disseminated intravascular coagulation (30.8% vs. 8.3%) and macrophage activation syndrome (19.2% vs. 2.8%) than the younger onset group. Cytomegalovirus infections were frequent in elderly onset patients (38.5% vs. 13.9%) but decreased with early glucocorticoid dose reduction and increased immunosuppressant and tocilizumab use. Elderly AOSD is not uncommon; these patients have different characteristics than younger-onset patients. Devising a way to control disease activity quickly while managing infections may be an important goal in elderly AOSD., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
43. Hypertrophic pachymeningitis in polyarteritis nodosa: a case-based review.
- Author
-
Nomura S, Shimojima Y, Kondo Y, Kishida D, and Sekijima Y
- Subjects
- Aged, Dura Mater diagnostic imaging, Female, Humans, Hypertrophy, Magnetic Resonance Imaging, Cranial Nerve Diseases, Meningitis diagnostic imaging, Meningitis drug therapy, Polyarteritis Nodosa complications, Polyarteritis Nodosa diagnostic imaging, Polyarteritis Nodosa drug therapy
- Abstract
Hypertrophic pachymeningitis (HP) is a rare neurological disorder with focal or diffuse thickening of the dura mater, which usually causes headache, cranial neuropathies, seizures, and motor or sensory impairments. The development of HP is attributed to an immune-mediated mechanism, and some autoimmune diseases have been implicated in the development of HP. Herein, we describe the case of a 73-year-old woman with persistent headache ascribable to HP, which developed approximately 3 years after a diagnosis of polyarteritis nodosa (PAN). She was treated with high-dose corticosteroid and cyclophosphamide that resulted in immediate disappearance of headache and improved radiological findings of thickened dura mater. In addition, she was subsequently administered methotrexate, ultimately resulting in maintenance of remission and regular reduction of prednisolone. In our review of published English articles, only two cases of HP in patients with PAN have been reported to date, suggesting that HP is a rare complication in PAN. However, it should be recognized that HP may develop as a neurological involvement related to PAN., (© 2021. International League of Associations for Rheumatology (ILAR).)
- Published
- 2022
- Full Text
- View/download PDF
44. Oxidative Stress Promotes Instability of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Author
-
Shimojima Y, Kishida D, Ichikawa T, Takamatsu R, Nomura S, and Sekijima Y
- Subjects
- Antioxidants pharmacology, Case-Control Studies, Cells, Cultured, Cytokines metabolism, Female, Forkhead Transcription Factors metabolism, Granulomatosis with Polyangiitis blood, Granulomatosis with Polyangiitis immunology, Humans, Male, Microscopic Polyangiitis blood, Microscopic Polyangiitis immunology, Middle Aged, Phenotype, Phosphorylation, Reactive Oxygen Species metabolism, Resveratrol pharmacology, Signal Transduction, Sirtuin 1 metabolism, T-Lymphocytes, Regulatory drug effects, T-Lymphocytes, Regulatory immunology, TOR Serine-Threonine Kinases metabolism, Antibodies, Antineutrophil Cytoplasmic blood, Granulomatosis with Polyangiitis metabolism, Microscopic Polyangiitis metabolism, Oxidative Stress drug effects, T-Lymphocytes, Regulatory metabolism
- Abstract
We investigated the characteristics of regulatory T cells (Tregs), focusing on the relationship between their stability and reactive oxygen species (ROS), in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Intracellular expressions of effector cytokines, forkhead box protein 3 (FoxP3), ROS, phosphorylated mammalian target of rapamycin (mTOR), and sirtuin 1 (SIRT1) in Tregs from peripheral blood mononuclear cells (PBMCs) of patients with AAV and healthy controls (HC) were analyzed. The alterations in and functional ability of Tregs were compared before and after resveratrol (RVL) treatment of PBMCs in patients with AAV. Significantly higher expressions of interferon (IFN)-γ, interleukin (IL)-17, IL-4, ROS, and phosphorylated mTOR (pho-mTOR) and lower expression of SIRT1 in CD4+CD25+FoxP3+ cells were found in patients with AAV than in the HC. FoxP3 expression in CD4+CD25+ cells and suppressive function of Tregs were significantly lower in patients with AAV than in the HC. Tregs after RVL treatment demonstrated significant decreases in IFN-γ, ROS, and pho-mTOR levels and increases in FoxP3, SIRT1 levels, and functional activity. Conversely, the direct activation of SIRT1 by SRT1720 resulted in decreased FoxP3 expression, with no reduction in ROS levels. The pho-mTOR levels were significantly higher in Tregs after activation by SRT1720 than in those after RVL treatment. This study suggested that imbalanced changes in Tregs could be attributed to mTOR activation, in which ROS overproduction was predominantly implicated. Therefore, ROS is a key mediator for promoting Tregs instability in AAV., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Shimojima, Kishida, Ichikawa, Takamatsu, Nomura and Sekijima.)
- Published
- 2021
- Full Text
- View/download PDF
45. Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
- Author
-
Shimojima Y, Ichikawa T, Kishida D, Takamatsu R, and Sekijima Y
- Subjects
- Acute Disease, Cytokines blood, Female, Humans, Male, Middle Aged, Patient Acuity, Still's Disease, Adult-Onset blood, Still's Disease, Adult-Onset therapy, T-Lymphocytes, Regulatory metabolism, Cytokines immunology, Gene Expression Regulation immunology, Still's Disease, Adult-Onset immunology, T-Lymphocytes, Regulatory immunology
- Abstract
We investigated the characteristics of regulatory T cells in adult-onset Still's disease (AOSD) with a focus on their plasticity, stability and relationship to disease severity. The proportion of circulating CD4
+ CD25+ forkhead box protein 3 (FoxP3+ ) cells (Tregs ) and intracellular expression of effector cytokines, including interferon (IFN)-γ, interleukin (IL)-17 and IL-4, was analysed in 27 untreated patients with AOSD (acute AOSD), 11 of the 27 patients after remission and 16 healthy controls (HC) using flow cytometry. The suppressive ability of Tregs was also evaluated. Regression analyses of the results were performed. The proportion of Tregs was significantly lower in patients with acute AOSD than in the HC. The expression levels of IFN-γ, IL-17 and IL-4 in Tregs were significantly increased in patients with acute AOSD. IFN-γ and IL-4 expression levels were inversely correlated with the proportion of Tregs and positively correlated with serum ferritin levels. Decreased expression of FoxP3 in CD4+ CD25+ cells, which was correlated with increased expression of IL-17, and impaired suppressive function were observed in Tregs in acute AOSD. However, these aberrant findings in Tregs , including the reduced circulating proportion and functional ability and altered intracellular expression levels of cytokines and FoxP3, were significantly improved after remission. In acute AOSD, Tregs show plastic changes, including effector cytokine production and reductions in their proportion and functional activity. IFN-γ and IL-4 expression levels in Tregs may be associated with disease severity. Also, down-regulation of FoxP3 may be related to IL-17 expression in Tregs . Importantly, the stability of Tregs can be restored in remission., (© 2021 British Society for Immunology.)- Published
- 2021
- Full Text
- View/download PDF
46. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
- Author
-
Ichikawa T, Shimojima Y, Kishida D, Ueno KI, and Sekijima Y
- Subjects
- Adult, Aged, Biomarkers blood, Case-Control Studies, Female, Humans, Immunosuppressive Agents therapeutic use, Lymphocyte Count, Lymphocytes drug effects, Lymphocytes immunology, Male, Middle Aged, Predictive Value of Tests, Remission Induction, Severity of Illness Index, Still's Disease, Adult-Onset diagnosis, Still's Disease, Adult-Onset drug therapy, Still's Disease, Adult-Onset immunology, Treatment Outcome, Immunocompetence, Interferon-gamma blood, Interleukins blood, Lymphocytes metabolism, Still's Disease, Adult-Onset blood
- Abstract
Objective: To investigate the relationship between interferon-γ (IFN-γ), IFN-γ-producing immunocompetent cells, their related cytokines, and the clinical features in adult-onset Still's disease (AOSD)., Methods: Twenty-five patients with AOSD before initiating treatment (acute AOSD), 9 patients after remission (remission AOSD), and 12 healthy controls (HC) were included. Circulating IFN-γ-producing CD4+ and CD8+ cells, natural killer (NK) cells, and IFN-γ production in NK cells were evaluated by flow cytometry. Serum levels of IFN-γ, interleukin (IL)-6, IL-12, IL-15, and IL-18 were also measured. The obtained results were statistically analyzed with clinical findings., Results: Serum levels of IFN-γ, IL-6, IL-12, IL-18, intracellular expression of IFN-γ in CD4+, CD8+, and NK cells were significantly higher in acute AOSD than in HC. The proportion of NK cells was significantly lower in acute AOSD than in HC. Serum levels of IFN-γ and IFN-γ expression in CD4+ cells were significantly correlated with serum ferritin levels. The proportion of NK cells had a significant inverse correlation with serum IFN-γ levels. A lower proportion of NK cells was significantly noted in patients refractory to initial immunosuppressive treatment. In remission AOSD, serum levels of IL-6, IL-12, and IL-18 were significantly higher than in HC., Conclusion: Increased serum levels of IFN-γ, increased expression of IFN-γ in CD4+ cells, and decreased NK cell proportion correlate with disease activity in AOSD. Moreover, a lower proportion of NK cells may be useful for predicting a refractory clinical course. Meanwhile, increased serum levels of IL-6, IL-12, and IL-18 may persist after clinical remission., (© 2021 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
47. Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody.
- Author
-
Kishida D, Ushiyama S, Shimojima Y, Ueno KI, Kurashina JI, Shirai T, and Sekijima Y
- Subjects
- Adult, Autoantibodies, Female, Humans, Interferon-Induced Helicase, IFIH1, Dermatomyositis complications, Dermatomyositis diagnosis, Dermatomyositis drug therapy, Panniculitis diagnosis, Panniculitis drug therapy
- Abstract
Panniculitis, a rare cutaneous manifestation in patients with dermatomyositis (DM), usually presents as a painful erythematous lesion. We herein report a 32-year-old woman with panniculitis that appeared as an indurated plaque without pain or redness after a 4-month episode of clinically amyopathic DM during treatment with prednisolone and tacrolimus. She experienced no pain; however, the firmness and extent gradually worsened. Based on our findings, including the histopathological results, DM panniculitis was diagnosed. Azathioprine was additionally administered, leading to remission. DM panniculitis can develop as a painless induration during immunosuppressive treatment, and azathioprine may be a useful treatment.
- Published
- 2021
- Full Text
- View/download PDF
48. Mesenteric panniculitis in systemic lupus erythematosus showing characteristic computed tomography findings.
- Author
-
Nomura S, Shimojima Y, Yoshizawa E, Kondo Y, Kishida D, and Sekijima Y
- Subjects
- Abdominal Pain drug therapy, Aged, Fatigue drug therapy, Fatigue etiology, Female, Humans, Lupus Erythematosus, Systemic complications, Pancytopenia drug therapy, Panniculitis, Lupus Erythematosus diagnostic imaging, Prednisolone therapeutic use, Tacrolimus therapeutic use, Abdominal Pain etiology, Lupus Erythematosus, Systemic diagnostic imaging, Panniculitis, Peritoneal diagnostic imaging, Tomography, X-Ray Computed methods
- Published
- 2021
- Full Text
- View/download PDF
49. Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.
- Author
-
Ichikawa T, Shimojima Y, Kishida D, Kaneko T, and Sekijima Y
- Subjects
- Adult, Antibodies, Monoclonal, Humanized administration & dosage, Antineoplastic Agents, Immunological administration & dosage, Brain diagnostic imaging, Brain pathology, Female, Herpesvirus 4, Human isolation & purification, Humans, Immunosuppressive Agents administration & dosage, Lupus Vasculitis, Central Nervous System drug therapy, Lymphoma, Large B-Cell, Diffuse drug therapy, Lymphoma, Large B-Cell, Diffuse pathology, Lymphoma, Large B-Cell, Diffuse virology, Rituximab administration & dosage, Immunosuppression Therapy adverse effects, Lupus Vasculitis, Central Nervous System complications, Lymphoma, Large B-Cell, Diffuse complications
- Abstract
Primary central nervous system lymphoma (PCNSL) sometimes occurs in immune-compromised hosts or patients with autoimmune diseases. Some cohort studies have previously reported an increased risk of non-Hodgkin's lymphoma in systemic lupus erythematosus (SLE), while some cases of PCNSL in patients with SLE were reported. We present the case of PCNSL which developed in a patient with the active phase of neuropsychiatric SLE (NPSLE). Furthermore, we reviewed published English articles to confirm the characteristics of PCNSL related to SLE. To our knowledge, this is the first report of PCNSL occurring in NPSLE. Histology demonstrated B-cell lymphoma with a positive Epstein-Barr virus-encoded RNA. This patient recovered following surgical resection of the lymphoma, whole brain radiation therapy, intravenous infusion of rituximab (RTX), and administration of belimumab after RTX. Given the series of reviews, our report suggests that the persistence of damage in the central nervous system (CNS) and long-term exposure to immunosuppressants may impact oncogenic immune responses within the CNS, leading to PCNSL development.
- Published
- 2021
- Full Text
- View/download PDF
50. Moyamoya syndrome related to systemic lupus erythematosus developing during pregnancy: a case-based review.
- Author
-
Tanaka R, Shimojima Y, Ueno KI, Takasone K, Ichikawa T, Kishida D, and Sekijima Y
- Subjects
- Adult, Carotid Artery, Internal, Female, Humans, Pregnancy, Tacrolimus, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic drug therapy, Moyamoya Disease complications
- Abstract
Moyamoya syndrome (MMS) is a chronic cerebrovascular disorder characterized by occlusion or stenosis of the internal carotid arteries with the formation of abnormal collateral vascular networks. Moreover, the development of MMS, which is a distinct category from "moyamoya disease," is attributed to the underlying disease, while some cases of MMS related to systemic lupus erythematosus (SLE) have been previously reported. Herein, we present the case of a 29-year-old Japanese woman with SLE in whom intracranial hemorrhage ascribable to MMS developed during pregnancy. Craniotomy was performed to remove hematoma, and prednisolone, tacrolimus, and hydroxychloroquine were consecutively administered. She ultimately achieved remission and childbearing without the relapse of cerebrovascular event. To our knowledge, this is the first report of MMS associated with SLE in pregnancy. Through reviewing published English articles and our case, it was suggested that the pathogenesis of SLE is implicated in the development of moyamoya vasculopathy leading to cerebrovascular events. Moreover, pregnancy may affect the bleeding from the fragile collateral vessel wall.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.